• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/33

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

33 Cards in this Set

  • Front
  • Back

Pinpoint, non blanching hemorrhages as in the picture are called

Petechiae

Petechiae denotes what?

Decreased platelet number

Pseudothrombocytopenia

Due to hypocalcemia because of ETDA in CBC tubes.


Mechanism: Platelet agglutination via antibodies

Most common cause of Thrombocytopenia

Non prescription drugs and herbals.

Most common non-iatrogenic causes of Thrombocytopenia

Infections (bacterial and viral)


- decreases production and survival.

Examples of immuneediated thrombocytopenia

Infectious mononucleosis.


Early HIV (In Late HIV - decreased production).


Infection associtaed ITP in children.

What is it?


What are the DDs?

Macro-thrombocytopenia



DIfferentials :


May hegglin anomaly


Sebastian syndrome


Epstein's syndrome


Fechter syndrome

Evan's syndrome

AIHA + ITP

Examples of X linked inherited thrombocytopenia syndromes



X linked Thrombocytopenia

Wiskott Aldrich syndrome


Dyshematopoietic syndrome from GATA1 mutation



WAS GATA

A R thrombocytopenias

CAT (congenital amegakaryocytic thrombocytopenias)


Thrombocytopenia with absent radii


Bernard Soulier syndrome



A B CAT

Mortality rate in TTP without plasma exchange?

85-100% without treatment to 10-30% with plasma exchange

What is Upshaw Schulman syndrome?

Inherited TTP

Pathogenesis of idiopathic TTP

Antibodies to ADAMTS13



(Enzyme level < 10% are clearly associated)

People predisposed to TTP

Pregnancy.


HIV

Drug induced TTP

Antibody formation: Toclopidine, Clopidogrel.


Endothelial injury: Cyclosporine


Mitomycin C


CNI


Quinine



(Decreasing doses in the second group decreases microangiopathy)

True or False.



Idiopathic TTP is more common in men.

False.



Idiopathic TTP is related to antibodies to ADAMTS13.


It is more common with women.

In a patient presenting with new thrombocytopenia (with or without other features of TTP), how will you evaluate?

Lab data to ruleout DIC and evaluate for MAHA.



Findings in favour of TTP diagnosis:


Increased LDH


Indirect bilirubin


Low haptoglobulin


High Retic count


With Coombs negativity.



Peripheral smear for schistiocytes.

True or false.



Immature RBCs in peripheral blood in TTP is due to hemolysis and infarction of small vasculature in marrow.

True

Duration of plasma exchange in TTP

Until platelet count normalising or signs of hemolysis resolving for 2 days

TRUE OR FALSE.



Gluco corticoids can be used in TTP.

True.

Other agents that can be used in TTP

Rituximab


Vincristine


Cyclophosphamide


Splenectomy

Relapse rate in TTP

25-50% early relapse in 30 days.



Relapse correlates with severity of ADAMTS13.

Need for dialysis in children with typical HUS

40%, atleast for some period.

Overall mortality in typical HUS

< 5 %

Overall mortality in patients with aHUS

25%

True or flase.



aHUS is a diagnosis of exclusion.

True

Treatment for aHUS.

Eculizumab

Reason behind HUS.

Shiga like toxin form EHEC O157:H7.

Reason behind aHUS.

Chronic complement activation.

Reason behind TTP.

ADAMTS 13 deficiency

True or false.



Plasma exchange is useful in aHUS and so plasma exchange is done.


False.


aHUS may be initially treated with plasma exchange until ADAMTS13 levels are obtained and the diagnosis more clear. (ie TTP rules out)



Plasma exchange has no benefit in clinical outcomes.

DIfferentials for Thrombocytosis

Iron deficiency.


Reactive Thrombocytosis (inflammation, cancer or infection).


MPNs.


Rarely, 5q deletion MDS

Enzymes inportant for metabolism and regeneration of vitamin K

ɣ glutamyl carboxylase (GGCX)


Epoxide reductase (VKORC1)